A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions

• Status: Withdrawn
• Trial end date: 2010-07-22
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare bioavailability between formulations of alprazolam in tablets to determine their bioequivalence in terms of rate and magnitude of absorption.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Pfizer; Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
• Collaborator: Investigacion Farmacologica y Biofarmaceutica, S.A. de C.V.
• Treatments: Alprazolam

Criteria

Inclusion Criteria:

• Healthy volunteers (male or female)

• Age between 18-40 years

• body mass index (Quetelet´s index) between 18-27

Exclusion Criteria:

• Unhealthy subjects

• Volunteers who require any medication over the course of the study

• Volunteers who have received investigational drugs within 60 days prior to the study